[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2002024886A3 - Regulation of human serine protease - Google Patents

Regulation of human serine protease Download PDF

Info

Publication number
WO2002024886A3
WO2002024886A3 PCT/EP2001/011006 EP0111006W WO0224886A3 WO 2002024886 A3 WO2002024886 A3 WO 2002024886A3 EP 0111006 W EP0111006 W EP 0111006W WO 0224886 A3 WO0224886 A3 WO 0224886A3
Authority
WO
WIPO (PCT)
Prior art keywords
serine protease
human serine
regulation
reagents
regulate
Prior art date
Application number
PCT/EP2001/011006
Other languages
French (fr)
Other versions
WO2002024886A2 (en
Inventor
Rainer H Kohler
Original Assignee
Bayer Ag
Rainer H Kohler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Rainer H Kohler filed Critical Bayer Ag
Priority to AU2002213949A priority Critical patent/AU2002213949A1/en
Publication of WO2002024886A2 publication Critical patent/WO2002024886A2/en
Publication of WO2002024886A3 publication Critical patent/WO2002024886A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Reagents which regulate human serine protease activity and reagents which bind to human serine protease gene products can be used to regulate extracellular matrix degradation. Such regulation is particularly useful for treating cancer (including metastasis of malignant cells and tumor angiogenesis), inflammation, atherosclerosis and other cardiovascular diseases, neurodegenerative diseases, such as Alzheimer's disease, chronic obstructive pulmonary disease, and pathogenic infections.
PCT/EP2001/011006 2000-09-25 2001-09-24 Regulation of human serine protease WO2002024886A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002213949A AU2002213949A1 (en) 2000-09-25 2001-09-24 Regulation of human serine protease

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US23498400P 2000-09-25 2000-09-25
US60/234,984 2000-09-25
US30146801P 2001-06-29 2001-06-29
US60/301,468 2001-06-29
US30718701P 2001-07-24 2001-07-24
US60/307,187 2001-07-24

Publications (2)

Publication Number Publication Date
WO2002024886A2 WO2002024886A2 (en) 2002-03-28
WO2002024886A3 true WO2002024886A3 (en) 2002-11-07

Family

ID=27398670

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/011006 WO2002024886A2 (en) 2000-09-25 2001-09-24 Regulation of human serine protease

Country Status (2)

Country Link
AU (1) AU2002213949A1 (en)
WO (1) WO2002024886A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014072941A1 (en) 2012-11-09 2014-05-15 Marco Archetti Diffusible factors and cancer cells

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999040183A1 (en) * 1998-02-06 1999-08-12 Human Genome Sciences, Inc. Human serine protease and serpin polypeptides
WO1999049055A1 (en) * 1998-03-20 1999-09-30 Smithkline Beecham Biologicals S.A. Human casb12 polypeptide, a serine protease
WO2001024815A1 (en) * 1999-10-07 2001-04-12 Human Genome Sciences, Inc. Plasminogen-like polynucleotides, polypeptides, and antibodies
WO2002000860A2 (en) * 2000-06-26 2002-01-03 Sugen, Inc. Novel proteases

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999040183A1 (en) * 1998-02-06 1999-08-12 Human Genome Sciences, Inc. Human serine protease and serpin polypeptides
WO1999049055A1 (en) * 1998-03-20 1999-09-30 Smithkline Beecham Biologicals S.A. Human casb12 polypeptide, a serine protease
WO2001024815A1 (en) * 1999-10-07 2001-04-12 Human Genome Sciences, Inc. Plasminogen-like polynucleotides, polypeptides, and antibodies
WO2002000860A2 (en) * 2000-06-26 2002-01-03 Sugen, Inc. Novel proteases

Also Published As

Publication number Publication date
AU2002213949A1 (en) 2002-04-02
WO2002024886A2 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
WO2001096538A3 (en) Regulation of human transmembrane serine protease
Sorsa et al. A trypsin‐like protease from Bacteroides gingivalis: partial purification and characterization
Ganea et al. Matrix metalloproteinases: useful and deleterious
AU2001259353A1 (en) Novel mutated form of arginine deiminase
YU31801A (en) Anthranilic acid amides and the use thereof as medicaments
WO2003032994A3 (en) Novel tri-substituted pyrimidines, method for production and use thereof as medicament
NO20000410L (en) Dipeptide and related compounds that inhibit leukocyte adhesion mediated by VLA-4
WO2002008392A3 (en) Regulation of human matriptase-like serine protease
WO2001096298A3 (en) 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
Sangeetha et al. Anti-inflammatory activity of a serine protease produced from Bacillus pumilus SG2
WO2002024886A3 (en) Regulation of human serine protease
WO2001096378A3 (en) Human epithin-like serine protease
WO2002014264A3 (en) (hydroxyethyl)ureas as inhibitors of alzheimer's beta-amyloid production
WO2001098467A3 (en) Regulation of human prostasin-like serine protease
WO2002026957A3 (en) Regulation of a human serine protease
WO2002012461A3 (en) Regulation of human membrane-type serine protease
WO2001098340A3 (en) Regulation of human mast cell protease 6-like enzyme
WO2001098466A3 (en) Regulation of human prostasin-like serine protease
WO2001079466A3 (en) Regulation of human epithin-like serine protease
WO2002000702A3 (en) Regulation of human epidermis-specific serine protease
WO2001072973A3 (en) Regulation of human heparanase-like enzyme
WO2001062941A3 (en) Regulation of human gelatinase b-like enzyme 2
AU2002251788A1 (en) Novel compounds and uses thereof
WO2002002755A3 (en) Regulation of human thimet oligopeptidase-like enzyme
WO2001090160A3 (en) REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP